Biofrontera Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biofrontera Inc. (BFRI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-17.76-20.13-0.64-37.71-10.99
Depreciation & Amortization1.151.061.170.540.56
Stock Based Compensation1.021.051.850.130.00
Change in Working Capital6.21-4.392.79-1.51-2.83
Change in Accounts Receivable-0.32-1.54-0.07-0.611.17
Change in Inventory4.23-3.75-2.812.59-0.27
Change in Accounts Payable-1.816.420.91-0.77-3.40
Change in Other Working Capital4.10-6.884.76-2.71-0.32
Other Operating Activities-1.07-6.88-3.4411.790.90
Net Cash from Operating Activities-10.27-24.90-16.20-26.72-12.37
Investing Activities
Capital Expenditures-0.010.00-0.04-0.010.00
Acquisitions0.000.100.000.000.00
Purchases of Investments0.060.62-5.120.000.00
Sales/Maturities of Investments-0.050.62-5.120.000.00
Other Investing Activities-0.050.000.000.000.00
Net Cash from Investing Activities0.000.62-5.16-0.010.00
Financing Activities
Debt Repayment-4.32-21.340.000.000.00
Common Stock Issued7.444.519.3943.190.00
Other Financing Activities15.100.000.000.004.40
Net Cash from Financing Activities14.848.4114.0243.1913.19
Summary
Net Change in Cash4.56-15.87-7.3316.470.83
Cash at Beginning of Period1.5417.4124.748.280.00
Cash at End of Period6.111.5417.4124.740.00
Free Cash Flow-10.28-24.90-16.24-26.73-12.37
Supplemental Disclosures
Interest Paid1.730.130.000.003.07
Income Taxes Paid0.020.020.030.060.06